Charles Schwab Investment Management Inc Evelo Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $519 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.86 - $41.8 $163,534 - $3.68 Million
-87,922 Reduced 73.72%
31,345 $66,000
Q2 2022

Aug 15, 2022
SELL
$1.46 - $3.55 $125,174 - $304,362
-85,736 Reduced 41.82%
119,267 $252,000
Q1 2022

May 13, 2022
BUY
$2.66 - $6.63 $8,895 - $22,170
3,344 Added 1.66%
205,003 $695,000
Q4 2021

Feb 11, 2022
BUY
$6.07 - $12.0 $42,332 - $83,688
6,974 Added 3.58%
201,659 $1.23 Million
Q3 2021

Nov 16, 2021
BUY
$6.79 - $13.9 $17,002 - $34,805
2,504 Added 1.3%
194,685 $1.37 Million
Q2 2021

Aug 16, 2021
BUY
$9.43 - $16.6 $205,470 - $361,697
21,789 Added 12.79%
192,181 $2.64 Million
Q1 2021

May 17, 2021
BUY
$9.71 - $18.6 $367,348 - $703,675
37,832 Added 28.54%
170,392 $1.82 Million
Q4 2020

Feb 16, 2021
SELL
$3.91 - $12.28 $45,801 - $143,847
-11,714 Reduced 8.12%
132,560 $1.6 Million
Q3 2020

Nov 13, 2020
BUY
$3.81 - $5.73 $270,068 - $406,165
70,884 Added 96.59%
144,274 $761,000
Q2 2020

Aug 14, 2020
BUY
$3.53 - $6.12 $18,214 - $31,579
5,160 Added 7.56%
73,390 $360,000
Q1 2020

May 15, 2020
BUY
$3.21 - $7.06 $3,226 - $7,095
1,005 Added 1.49%
68,230 $257,000
Q4 2019

Feb 07, 2020
SELL
$3.81 - $7.45 $33,688 - $65,872
-8,842 Reduced 11.62%
67,225 $273,000
Q3 2019

Nov 08, 2019
BUY
$5.45 - $8.8 $174,203 - $281,283
31,964 Added 72.48%
76,067 $465,000
Q2 2019

Aug 09, 2019
BUY
$6.52 - $9.42 $20,133 - $29,088
3,088 Added 7.53%
44,103 $397,000
Q1 2019

May 14, 2019
BUY
$7.5 - $15.31 $3,555 - $7,256
474 Added 1.17%
41,015 $329,000
Q4 2018

Feb 14, 2019
BUY
$7.29 - $13.01 $120,824 - $215,627
16,574 Added 69.15%
40,541 $528,000
Q3 2018

Nov 13, 2018
BUY
$11.93 - $14.76 $16,546 - $20,472
1,387 Added 6.14%
23,967 $292,000
Q2 2018

Aug 08, 2018
BUY
$11.39 - $16.26 $257,186 - $367,150
22,580 New
22,580 $267,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email